Proto Labs, Inc. (PRLB) Market Cap & Valuation Ratios
Proto Labs, Inc. (PRLB) has a market cap of $2.0B, a trailing P/E of 68.5 and a price-to-sales ratio of 3.6, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PRLBProto Labs, Inc.Follow PRLB — free
—
Price chart with a free account
- Market cap
- 2.0B
- P/E TTM
- 68.5
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
Peers
metal fabrication · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| PRLB | 2.0 | 68.5 | 3.4 | 27.4 | 2.8% | +10% | 7% | 5% |
| MLI | 12 | 13.8 | 2.1 | 9.0 | 5.8% | +21% | 22% | 42% |
| CMC | 6.9 | 10.7 | 1.0 | 7.6 | 6.9% | +20% | 9% | 13% |
| ESAB | 4.2 | 24.1 | 2.1 | 13.7 | 4.7% | +10% | 12% | 8% |
| DPC | 3.8 | — | — | — | — | — | -54% | — |
| GPGI | 3.3 | — | — | — | -2.1% | — | -23% | -3% |
| WOR | 3.1 | 19.2 | 2.4 | 24.2 | 6.3% | +18% | 6% | 5% |
| RYZ | 1.5 | — | 0.4 | 20.6 | -9.0% | +32% | 0.3% | 0.8% |
| ELMT | 0.7 | — | — | — | — | — | — | — |
| PKOH | 0.6 | 22.8 | 0.7 | 11.8 | 3.3% | +3% | 4% | 6% |
| IIIN | 0.5 | 14.9 | 0.7 | 7.9 | -1.8% | +17% | 7% | 11% |
| Median of these 10 | 17.0 | 1.0 | 11.8 | 4.0% | +18% | 6% | 7% |
P/E 68.5 vs. a peer median of 17.0; EV/Sales 3.4 vs. 1.0. PRLB's own P/E sits at the 74th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesDPC and GPGI and RYZ and ELMT have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Proto Labs, Inc. — questions
- What is Proto Labs, Inc.'s market cap?
- $2.0B.
- What is Proto Labs, Inc.'s P/E ratio?
- 68.5 on trailing twelve-month earnings to 2026-06-30.
- What is Proto Labs, Inc.'s price-to-sales ratio?
- 3.6.
Every figure on this page comes from Proto Labs, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.